Trials / Completed
CompletedNCT03307122
Gastrointestinal Tolerance Evaluation of an Infant Formula
Infant Formula GI Tolerance Evaluation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 9 Days – 19 Days
- Healthy volunteers
- Accepted
Summary
Prospective, double-blind, randomized study of 2 infant formulas.
Detailed description
Exclusively formula-fed infants will participate in a 6-week feeding period of an infant formula. Tolerance records will be kept for 2 days at the end of the 6-week period by caregivers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Routine Infant Formula 1 | Routine infant formula with probiotic |
| OTHER | Routine Infant Formula 2 | Routine infant formula with probiotic and prebiotic |
Timeline
- Start date
- 2017-09-21
- Primary completion
- 2018-01-19
- Completion
- 2018-01-19
- First posted
- 2017-10-11
- Last updated
- 2018-05-23
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03307122. Inclusion in this directory is not an endorsement.